Nasal Cannula Market to Witness Exponential Growth by 2027

Comments · 310 Views

The Global Nasal Oxygen Tube Market was valued at USD 4.73 Billion in 2019 and is projected to attain a value of USD 10.12 Billion by the end of the forecast period in 2027, registering a CAGR of 7.7%.

According to the current analysis of Reports and Data, the global Nasal Cannula Market was valued at USD 4.4 Billion in 2018 and is expected to reach USD 9.4 Billion by year 2026, at a CAGR of 7.7%. The market for Nasal Cannula is growing out of critical customer needs. The Nasal Cannula industry that has grown from its nascent to the advanced stages very rapidly. Nasal Cannula market can be divided into several segments and sub-segments. It includes services ranging from unskilled care to skilled nursing. The product range is also very wide, and so is the scope and need for specializations.

High-flow nasal cannula (HFNC), under the Product Type segment, is expected to grow the fastest during the forecast period. High-flow nasal cannula (HFNC) oxygen therapy comprises an air/oxygen blender, an active humidifier, a single heated circuit, and a nasal cannula. It delivers adequately heated and humidified medical gas at up to 60 L/min of flow and is considered to have a number of physiological effects: reduction of anatomical dead space, constant fraction of inspired oxygen, and good humidification. Increasing paediatric healthcare need and a growing geriatric population worldwide are the main industry drivers. Coupled with these are the increasing incidences of chronic respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD), asthma, pneumonia and so on. These diseases need urgent hospitalisation and care, and upon hospitalisation, patients require nasal oxygen tubing to restore their respiratory functions. As developing countries are investing in healthcare, the scourge of cross-contamination and hospital acquired infection (HAI) need to be addressed. Thus, the demand for single use Nasal Cannulas is increasing, which will be positively affecting industry growth. Worldwide population older than 60 years might reach to 2 billion by 2050, according to WHO, which might lead to increasing chronic respiratory diseases being diagnosed which augments the demand for nasal cannulas. Nasal Cannulas are very cost effective and now come in many product variants which look into aspects like patient comfort while using the products. Ultra-soft nasal tubes, as being manufactured by Smith Medical and Salter Labs is expected to drive industry growth. It has a ready and growing demand today. The North American region was the industry leader in 2018, due to very high investments in healthcare, while Asia Pacific is expected to witness the highest CAGR in the coming years.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2128

Further key findings from the report suggest-

  • Increasing number of respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD), asthmas and so on are multiplying the need of Nasal Cannula interventions.
  • North America has the leading share in the Nasal Cannula industry chiefly because of the converging trends of their ageing population, rise in the number and cases of chronic diseases and significant investments in healthcare.
  • Asia Pacific region will witness the highest CAGR in the Nasal Cannula sector during the forecast period on account of cost advantages, rise in the numbers of the ailing population and an increased need of hygiene-based healthcare in public and private. 10% of healthcare investment in RD is expected by 2019
  • China and India are expected to witness a huge surge in the Nasal Cannula market, as the market value is expected to double itself in India shortly. As more number of aged population is expected to be residing in China and Asia Pacific region by 2050, along with increased healthcare spending by their respective governments, the use of these products is expected to increase.
  • Developing countries are increasing their public healthcare spending, and as such, the number of hospitals and clinics is expected to increase where these products are used to a huge extent.
  • These products are popular primarily due to the advantage of oxygen intake regulation, which most of them have.
  • By product type, High-flow Nasal Cannula occupies the largest market share and is expected to grow at the highest CAGR.
  • Latin America and Middle East and Africa will also be showing an average growth of around 13.2% till 2026. In Latin America, the healthcare cost is considerably low, and these products are a good investment by hospitals in the region to provide safe and effective care to patients.
  • A rise in the disposable income, increasing awareness about these products, improved sources of funding and greater technological and scientific innovations boost the industry.

Competitive Outlook of the Global Nasal Cannula Market

The globla Nasal Cannula market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Nasal Cannula market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

Flexicare Limited (UK), Salter Labs (USA), Smiths Medical Inc (USA), Teleflex Inc (USA), Fairmont Medical (Australia), Hamilton Medicals (Switzerland), Neotech Products (USA) and Sunset Healthcare Solutions Inc (USA) amongst others operate in the marketplace.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2128

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Nasal Cannula Market Segmentation:

Product Type

  • Low-flow Nasal Cannula
  • High-flow Nasal Cannula

Applications

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Respiratory Failure
  • Carbon Monoxide Toxicity
  • Bronchiectasis
  • Others

End Users

  • Hospitals
  • Ambulatory Service Centres (ASC)
  • Others

Geographic Segment Covered in the Report:

The Nasal Cannula report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2128

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Microscopy Devices Market @ https://www.biospace.com/article/microscopy-devices-market-share-comprehensive-analysis-opportunity-assessment-future-estimations-and-key-industry-segments-poised-for-strong-growth-in-future-2028/

Galantamine Hydrobromide Market @ https://www.biospace.com/article/galantamine-hydrobromide-market-size-industry-statistics-growth-potentials-trends-company-profile-global-expansion-strategies-by-top-key-vendors-till-2028/

Acute Viral Rhinosinusitis Treatment Market @ https://www.biospace.com/article/acute-viral-rhinosinusitis-treatment-market-share-size-key-players-trends-competitive-and-regional-forecast-to-2028/

Tuberculosis Testing Market @ https://www.biospace.com/article/tuberculosis-testing-market-insights-future-trends-on-going-demand-opportunities-segmentation-and-forecast-till-2028/

Spinal Traction Market @ https://www.biospace.com/article/spinal-traction-market-size-share-growth-sales-revenue-and-key-drivers-analysis-research-report-by-2028/

Pediatric Radiology Market @ https://www.biospace.com/article/pediatric-radiology-market-share-comprehensive-analysis-opportunity-assessment-future-estimations-and-key-industry-segments-poised-for-strong-growth-in-future-2028/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Comments